“The University of Pennsylvania, which hosts Joe Biden’s think tank the Penn Biden Center and paid Joe Biden in the lead-up to his run for president, got paid by the company Bavarian Nordic to perform a clinical trial on the Bavarian Nordic monkeypox vaccine,” Patrick Howley writes in NATIONAL FILE.
The University of Pennsylvania Hospital, where a globalist think tank called the Penn Biden Center is located, is receiving loads of cash for helping with the monkeypox vaccine, giving Biden the ability to profit greatly from the shots.— James 1776 🇺🇸 (@Chardwa13) May 26, 2022
Biden’s think tank, the Piedmont Penn Center, has received funds and will allegedly continue to profit from monkeypox vaccines. Potential conflict of interest to approve monkeypox funds that indirectly end at your think tank.https://t.co/YEf9IcJOm2— Divine Pear (@Concernedpear) May 26, 2022
According to a University of Pennsylvania document obtained by NATIONAL FILE, Joe Biden’s host university profited from helping Bavarian Nordic develop the MVA-BN monkeypox vaccine.
The MVA-BN vaccine tested at UPenn is now known in America as the Jynneos monkeypox vaccine.
From NATIONAL FILE:
“The University of Pennsylvania is being paid by Bavarian Nordic,” the 2014 document states. Biden joined UPenn after leaving the vice presidency in 2017. Anthony Fauci used approximately $100 million in U.S. taxpayer funds to pay Bavarian Nordic for the vaccine and the Biden administration has used over $100 million in taxpayer funds to buy the monkeypox vaccines.
As I also reported, the University of Pennsylvania makes massive money off Coronavirus vaccines. UPenn gets paid by Pfizer’s vaccine partner BioNtech in licensing payments for mRNA technology and UPenn even makes more money if Pfizer-BioNTech sells more vaccines and gets more FDA approvals from the Biden administration, thanks to a deal UPenn made in 2018 when Biden worked for the university.
Here is the University of Pennsylvania document for the Hospital of the University of Pennsylvania that invites people to participate in a research study called “Randomized, open-label Phase II trial to assess the safety and immunogenicity of MVA-BN® smallpox vaccine when increasing the number of injections compared to the standard regimen in immunocompromised subjects with HIV infection…”
The document states that “The University of Pennsylvania is being paid by Bavarian Nordic, the sponsor of this trial who is also providing the material to conduct this research trial.”
Read the full document HERE.
Patrick Howley joined Owen Shroyer of Infowars to deliver breaking news about the pharmaceutical corruption of Joe Biden and his connection to the monkeypox virus.
Howley explained, “Joe Biden stands to benefit from the monkeypox vaccine.”
Watch Howley break the news to Shroyer on Infowars.
Read Howley’s full report at NATIONAL FILE.